These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37160166)

  • 1. Defining severe NAFLD based on ICD codes in large cohorts: Balancing feasibility and limitations.
    Long L; Zhou X
    J Hepatol; 2023 Dec; 79(6):e232-e233. PubMed ID: 37160166
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: "Defining severe NAFLD based on ICD codes in large cohorts: Balancing feasibility and limitations".
    Petermann-Rocha F; Ho FK; Pell JP
    J Hepatol; 2023 Dec; 79(6):e233-e234. PubMed ID: 37607622
    [No Abstract]   [Full Text] [Related]  

  • 3. Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM.
    Hayward KL; Johnson AL; Horsfall LU; Moser C; Valery PC; Powell EE
    BMJ Open Gastroenterol; 2021 Feb; 8(1):. PubMed ID: 33568418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administrative coding for non-alcoholic fatty liver disease is accurate in Swedish patients.
    Åström H; Wester A; Hagström H
    Scand J Gastroenterol; 2023; 58(8):931-936. PubMed ID: 36890670
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
    Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
    PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
    Zhou JH; Cai JJ; She ZG; Li HL
    World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frequency of diagnosed non-alcololic fatty liver disease (NAFLD) in the German population - An analysis based on health insurance data].
    Stahmeyer JT; Hemmerling M; Burger B; Eberhard S; Krauth C; Zeidler J; Herr A; Weseloh H; Rossol S
    Z Gastroenterol; 2021 Aug; 59(8):851-858. PubMed ID: 33757144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement.
    Hagström H; Adams LA; Allen AM; Byrne CD; Chang Y; Grønbaek H; Ismail M; Jepsen P; Kanwal F; Kramer J; Lazarus JV; Long MT; Loomba R; Newsome PN; Rowe IA; Ryu S; Schattenberg JM; Serper M; Sheron N; Simon TG; Tapper EB; Wild S; Wong VW; Yilmaz Y; Zelber-Sagi S; Åberg F
    Hepatology; 2021 Jul; 74(1):474-482. PubMed ID: 33486773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease is not a causal risk factor for psoriasis: A Mendelian randomization study of 108,835 individuals.
    Näslund-Koch C; Bojesen SE; Gluud LL; Skov L; Vedel-Krogh S
    Front Immunol; 2022; 13():1022460. PubMed ID: 36353626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD.
    Corey KE; Pitts R; Lai M; Loureiro J; Masia R; Osganian SA; Gustafson JL; Hutter MM; Gee DW; Meireles OR; Witkowski ER; Richards SM; Jacob J; Finkel N; Ngo D; Wang TJ; Gerszten RE; Ukomadu C; Jennings LL
    J Hepatol; 2022 Jan; 76(1):25-33. PubMed ID: 34600973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort.
    Harrison SA; Gawrieh S; Roberts K; Lisanti CJ; Schwope RB; Cebe KM; Paradis V; Bedossa P; Aldridge Whitehead JM; Labourdette A; Miette V; Neubauer S; Fournier C; Paredes AH; Alkhouri N
    J Hepatol; 2021 Aug; 75(2):284-291. PubMed ID: 33746083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus infection and the risk of liver disease progression in type 2 diabetic patients with potential nonalcoholic fatty liver disease: a retrospective, observational, cohort study in the United Kingdom Clinical Practice Research Datalink.
    Ferreira G; Stuurman AL; Horsmans Y; Cattaert T; Verstraeten T; Feng Y; Rosillon D; Guignard A
    Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):101-109. PubMed ID: 31651649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Referral care paths for non-alcoholic fatty liver disease-Gearing up for an ever more prevalent and severe liver disease.
    van Dijk AM; Schattenberg JM; Holleboom AG; Tushuizen ME
    United European Gastroenterol J; 2021 Oct; 9(8):903-909. PubMed ID: 34609086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries.
    Fudim M; Zhong L; Patel KV; Khera R; Abdelmalek MF; Diehl AM; McGarrah RW; Molinger J; Moylan CA; Rao VN; Wegermann K; Neeland IJ; Halm EA; Das SR; Pandey A
    J Am Heart Assoc; 2021 Nov; 10(22):e021654. PubMed ID: 34755544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients.
    Singh A; Le P; Peerzada MM; Lopez R; Alkhouri N
    J Clin Gastroenterol; 2018 Mar; 52(3):268-272. PubMed ID: 28787358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
    Qureshi K; Abrams GA
    Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction.
    Miller A; McNamara J; Hummel SL; Konerman MC; Tincopa MA
    Sci Rep; 2020 Jul; 10(1):12440. PubMed ID: 32709942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease.
    Staufer K; Huber-Schönauer U; Strebinger G; Pimingstorfer P; Suesse S; Scherzer TM; Paulweber B; Ferenci P; Stimpfl T; Yegles M; Datz C; Trauner M
    J Hepatol; 2022 Oct; 77(4):918-930. PubMed ID: 35605744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodontal disease could be a potential risk factor for non-alcoholic fatty liver disease: An 11-year retrospective follow-up study.
    Shin HS; Hong MH; Moon JY; Sim SJ
    Clin Oral Investig; 2022 Aug; 26(8):5503-5514. PubMed ID: 35556175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe.
    Lazarus JV; Ekstedt M; Marchesini G; Mullen J; Novak K; Pericàs JM; Roel E; Romero-Gómez M; Ratziu V; Tacke F; Cortez-Pinto H; Anstee QM;
    J Hepatol; 2020 Jan; 72(1):14-24. PubMed ID: 31518646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.